Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Sales/Fixed Asset

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.251.240.890.760.86

What is the latest Sales/Fixed Asset ratio of NATCO PHARMA ?

The latest Sales/Fixed Asset ratio of NATCO PHARMA is 1.25 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20251.25
Mar20241.24
Mar20230.89
Mar20220.76
Mar20210.86

How is Sales/Fixed Asset of NATCO PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.25
0.81
Mar2024 1.24
39.33
Mar2023 0.89
17.11
Mar2022 0.76
-11.63
Mar2021 0.86 -

Other Financial Ratios of NATCO PHARMA


Compare Sales/Fixed Asset ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,164.4 Cr 0.6% -4.9% -31.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.6%

-4.9%

-31.6%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses